Video

Cell Line Selection In Novel Protein Therapeutic Development

Source: Bioprocess Online

Lena Tholen, Ph.D, Director of Cell Line and Bioprocess Development at FyoniBio and Meinhard Hasslacher, Ph.D., Head of CMC at SOTIO Biotech weigh in early on important cell line selection considerations for novel protein therapeutics in this segment of the Bioprocess Online Live event Early Process Considerations For Novel Protein Therapeutics.

access the Video!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.

Subscribe to Bioprocess Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Bioprocess Online

Please tell us more about you so that we can customize our newsletters to your specific interests:

What topics interest you? (Check all that apply.)